Results 171 to 180 of about 18,762 (211)

Baricitinib could improve the prognosis of anti-MDA5 antibody positive dermatomyositis associated interstitial lung disease. [PDF]

Arthritis Res Ther
Zhu S, Li S, Shi L, Chu T, Huang Z, Lu X, Wang G, Ge Y.   +7 more
europepmc   +1 more source

JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology. [PDF]

Medicina (Kaunas)
Foggi G, D'Oria F, Falcidia C, Bianco M, Ibba L, Narcisi A, Costanzo A, Gargiulo L.   +7 more
europepmc   +1 more source

Potential benefits of JAK inhibitor therapy in Blau syndrome: a case report. [PDF]

Front Immunol
Wang Y, Yu XJ, Zhang Z.
europepmc   +1 more source

Evidence Synthesis Gone Awry: The Perils of Aggregating Ineffective or Unsafe Doses in Alopecia Areata Reviews. [PDF]

Cureus
Babul A, Mehta D, Soliman Y, Hussain M, Babul N.   +4 more
europepmc   +1 more source

Janus Kinase (JAK) Inhibitors in Rheumatoid Arthritis. [PDF]

Cureus
Burashed KK, AlAbbasi FA.
europepmc   +1 more source

Irish dermatologists' experience with JAK inhibitors in alopecia areata. [PDF]

Skin Health Dis
Grechin C, O'Kane M.
europepmc   +1 more source

Drug Survival in Atopic Dermatitis: Comparison of Biologics and JAK Inhibitors in the BioDay Registry. [PDF]

Allergy
van der Gang LF, Boesjes CM, Zuithoff NPA, Haeck I, Bacoş-Cosma O, Loman L, Atash K, Harbers V, Stadhouders S, Oosting AJ, van Lynden-van Nes AMT, Politiek K, Gostynski A, Christoffers WA, Garritsen FM, Flinterman A, Touwslager WRH, Velstra B, Stewart SM, van Erp FC, Galimont-Collen AFS, Schuttelaar MA, de Graaf M, de Bruin-Weller MS.   +23 more
europepmc   +1 more source

Resolution of Hashimoto thyroiditis with Janus kinase inhibitor therapy in a patient with alopecia universalis. [PDF]

JCEM Case Rep
Trost SU, Radulescu A.
europepmc   +1 more source

Case Report: Successful treatment of pediatric alopecia universalis with ritlecitinib after failure of baricitinib. [PDF]

Front Med (Lausanne)
Lv X, Chen Y, Ruan SF, Xu Q, Mao J, Zhu L, Xia W, Bao S, Zhuang Z, Chen L, Cheng B, Ji C.   +11 more
europepmc   +1 more source

T-cell-predominant inflammation in livedoid vasculopathy and response to baricitinib. [PDF]

JAAD Int
Wei DD, Nong ZX, Huang D, Wang SF, Huang KQ, Wen SJ.   +5 more
europepmc   +1 more source